Document is current
Any future updates will be listed below
-
Authors
Ouattara, Cheick Ahmed
Poda, Armel G
Méda, Ziemlé Clément
Sawadogo, Yacouba
Kabore, Odilon
Birba, Emile
Sourabié, Adama
Zoungrana, Jacques
Traore, Isidore Tiandiogo
Sangaré, Ibrahim
Ymba, Awa
Godreuil, Sylvain
Ouedraogo, Abdoul-Salam
-
Funding
Funding for this research was provided by:
Ministère de l’Europe et des Affaires Étrangères
- License Information
-
More Information
Article History
Received: 18 November 2022
Accepted: 13 February 2023
First Online: 22 February 2023
Declarations
:
: This project has been approved by the national ethics committee for health research of Burkina. Faso (N° 2021-08-192). The study will be performed in compliance with the latest revised version of the Helsinki [CitationRef removed], current legislation in Burkina Faso regarding clinical research, and the principles of Good Laboratory. Practice and Good Clinical [CitationRef removed]. The investigators and their designated representatives commit to respecting every aspect of the study protocol, particularly concerning the collection of informed consent and the notification and follow‑up of adverse events. All study participant to the study, will provide signed informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
